REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Berkanafarma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Berkanafarma S.A. Profile Updated: April 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Berkanafarma S.A. is an enterprise located in Ecuador, with the main office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Berkanafarma S.A. was incorporated on October 07, 2011. The total number of employees is currently 78 (2023). In 2023, the company reported a net sales revenue increase of 69.28%. There was a total growth of 45.63% in Berkanafarma S.A.’s total assets over the same period. The enterprise’s net profit margin decreased by 6.68% in 2023.

Headquarters
Interoceanica E28c, Centro de Negocios San Francisco Bldg. , Floor 003
Quito; Pichincha;

Contact Details: Purchase the Berkanafarma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Berkanafarma S.A. report to view the information.
Outstanding Shares:
Purchase the Berkanafarma S.A. report to view the information.
Registered Capital:
Purchase the Berkanafarma S.A. report to view the information.
Incorporation Date:
October 07, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Berkanafarma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
69.28%▲
Total operating revenue
56.14%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-92.74%▼
Total assets
45.63%▲
Total equity
-6.24%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-6.68%▼
Return on Equity (ROE)
-16.29%▼
Debt to Equity Ratio
1.68%▲
Quick Ratio
-0.33%▼
Cash Ratio
-0.13%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo